HIV / AIDS in the News

Cutaneous Squamous Cell Carcinoma Mimicking Kaposi Sarcoma in an HIV-Positive Patient: Diagnostic Challenges and Therapeutic Response to Liposomal Doxorubicin - Cureus

 

Novel HIV Combo Therapy of Lenacapavir and 2 bNAbs Found Effective, Well Tolerated in Phase 2 Trial - Infectious Disease Special Edition

 

From HIV to Global Cancer Prevention: A New Chapter in Global Health Financing - amfAR, The Foundation for AIDS Research

 

Gilead Sciences: HIV Treatments Propel Stocks - StocksToTrade

 

An injection to prevent HIV is something to celebrate - The Observer

 

UK's NICE Recommends ViiV Healthcare’s Injectable HIV Treatment - GSK (NYSE:GSK) - Benzinga

 

NICE recommends HIV prevention injection for people unable to take oral PrEP - The Pharmaceutical Journal

 

HIV Updates Put Comorbidities First — ART on Cruise Control - Medscape

 

UCF Team Advances Low-Cost Multiplex RNA Test for HIV, HBV, and HCV - Contagion Live

 

Investigational HIV bNAb N6LS Shown Safe, Tolerable in Phase 2b Trial - Infectious Disease Special Edition

 

Islatravir Lenacapavir HIV Treatment - Infectious Disease Special Edition

 

Islatravir Lenacapavir HIV Treatment - Infectious Disease Special Edition

 

ViiV Secures English Funding For First Long-Acting HIV Prevention Injection - insights.citeline.com

 

ViiV’s bi-monthly HIV injection approved by NICE - European Medical Journal

 

NHS to roll out first long-acting injection to prevent HIV - Wired-Gov

 

Record numbers accessing HIV prevention treatment | National Institute for Health and Clinical Excellence (NICE) - Wired-Gov

 

EACS 2025: Over Half of HIV Diagnoses in Migrants Occur Years Post-Migration - European Medical Journal

 

US aid cuts severely undermine Senegal’s fight against HIV - EL PAÍS English

 

NICE Endorses UK’s First Injectable PrEP to Curb HIV - Medscape

 

ViiV's bimonthly HIV PrEP jab cleared for use by NHS - pharmaphorum

 

Modeling the incidence rate of hospital re-admissions within 30 days and associated factors among patients with advanced HIV disease in Uganda: comparison of the performance of binary logistic and count regression models - BMC Public Health

 

Calgary-Founded Freddie Brings Affordable HIV Prevention Care To The USA - inmagazine.ca

 

ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain - Business Wire

 

NHS rolls out HIV prevention injection to eliminate transmissions by 2030 - Innovation News Network

 

England and Wales to get first long-lasting jab to prevent HIV - Euronews.com

 

Pepfar Bridge Plan gives South Africa's HIV/Aids efforts $115mln boost - ZAWYA

 

As Pennsylvania limits HIV support, some patients face soaring medical bills - 90.5 WESA

 

UK's drug-cost watchdog recommends use of GSK unit's HIV prevention drug - Reuters

 

Recognizing Haemophagocytic Lymphohistiocytosis in an HIV Patient With Disseminated Tuberculosis: Not Every Fever is Sepsis - Cureus

 

Long-acting injections for HIV to be rolled out by NHS in England - Nursing Times